Bio-Works Technologies AB (publ) (NGM:BIOWKS)

Bio-Works Technologies AB Statistics

Total Valuation

NGM:BIOWKS has a market cap or net worth of SEK 188.07 million. The enterprise value is 166.55 million.

Market Cap	188.07M
Enterprise Value	166.55M

Important Dates

The next estimated earnings date is Thursday, February 19, 2026.

Earnings Date	Feb 19, 2026
Ex-Dividend Date	n/a

Share Statistics

NGM:BIOWKS has 80.37 million shares outstanding. The number of shares has increased by 96.51% in one year.

Current Share Class	80.37M
Shares Outstanding	80.37M
Shares Change (YoY)	+96.51%
Shares Change (QoQ)	+1.93%
Owned by Insiders (%)	25.23%
Owned by Institutions (%)	10.41%
Float	40.76M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.05
PB Ratio	6.26
P/TBV Ratio	6.26
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-5.59
EV / Sales	3.59
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-5.81

Financial Position

The company has a current ratio of 2.26

Current Ratio	2.26
Quick Ratio	1.52
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-101.55

Financial Efficiency

Return on equity (ROE) is -67.92% and return on invested capital (ROIC) is -31.42%.

Return on Equity (ROE)	-67.92%
Return on Assets (ROA)	-23.05%
Return on Invested Capital (ROIC)	-31.42%
Return on Capital Employed (ROCE)	-73.34%
Revenue Per Employee	1.60M
Profits Per Employee	-1.03M
Employee Count	30
Asset Turnover	0.78
Inventory Turnover	0.99

Taxes

Income Tax	-31,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +170.27% in the last 52 weeks. The beta is 1.17, so NGM:BIOWKS's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	+170.27%
50-Day Moving Average	2.46
200-Day Moving Average	2.08
Relative Strength Index (RSI)	47.33
Average Volume (20 Days)	34,212

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NGM:BIOWKS had revenue of SEK 46.43 million and -29.78 million in losses. Loss per share was -0.38.

Revenue	46.43M
Gross Profit	35.12M
Operating Income	-22.04M
Pretax Income	-29.81M
Net Income	-29.78M
EBITDA	-21.69M
EBIT	-22.04M
Loss Per Share	-0.38

Balance Sheet

The company has 21.52 million in cash and n/a in debt, giving a net cash position of 21.52 million or 0.27 per share.

Cash & Cash Equivalents	21.52M
Total Debt	n/a
Net Cash	21.52M
Net Cash Per Share	0.27
Equity (Book Value)	30.04M
Book Value Per Share	0.37
Working Capital	28.41M

Cash Flow

In the last 12 months, operating cash flow was -28.49 million and capital expenditures -201,000, giving a free cash flow of -28.69 million.

Operating Cash Flow	-28.49M
Capital Expenditures	-201,000
Free Cash Flow	-28.69M
FCF Per Share	-0.36

Margins

Gross margin is 75.64%, with operating and profit margins of -47.46% and -64.14%.

Gross Margin	75.64%
Operating Margin	-47.46%
Pretax Margin	-64.21%
Profit Margin	-64.14%
EBITDA Margin	-46.73%
EBIT Margin	-47.46%
FCF Margin	n/a

Dividends & Yields

NGM:BIOWKS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-96.51%
Shareholder Yield	-96.51%
Earnings Yield	-15.83%
FCF Yield	-15.25%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

NGM:BIOWKS has an Altman Z-Score of -6.31 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6.31
Piotroski F-Score	2